NCT00442429

Brief Summary

Morbidity and Mortality among Dialysis Patients after Treating Depression Objectives Our investigation has two objectives:

  1. 1.To assess whether treatment and recovery from depression decreases adverse clinical events in chronic hemodialysis patients. Significant morbidity is associated with depression in dialysis patients, but subsequent impact on outcome after treatment of depression has not been reported.
  2. 2.To examine the rates of recovery from depression over a 6-month and 12-month period among prevalent dialysis patients. Rates of recovery among dialysis patients with depression are unclear. The natural history of depression among dialysis patients may help long-term management.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

March 1, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 2, 2007

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

March 2, 2007

Status Verified

March 1, 2007

First QC Date

March 1, 2007

Last Update Submit

March 1, 2007

Conditions

DepressionESRD

Keywords

depression; dialysis; kidney failure, chronic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ESRD age \> 18

You may not qualify if:

  • non english speaking, another psychiatric dx aside from depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Portland VA MC

Portland, Oregon, 97239, United States

RECRUITING

MeSH Terms

Conditions

DepressionKidney Failure, ChronicRenal InsufficiencyBronchiolitis Obliterans Syndrome

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorRenal Insufficiency, ChronicKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Study Officials

  • suzanne watnick, MD

    PVAMC physician

    PRINCIPAL INVESTIGATOR

Central Study Contacts

suzanne g watnick, MD

CONTACT

503-220-8262suzanne.watnick@med.va.gov

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
FED

Study Record Dates

First Submitted

March 1, 2007

First Posted

March 2, 2007

Study Start

July 1, 2004

Study Completion

June 1, 2010

Last Updated

March 2, 2007

Record last verified: 2007-03

Locations

US(1)